康泰生物(300601.SZ)：Sabin株脊髓灰质炎灭活疫苗(Vero细胞)获药品注册证书

Core Viewpoint - The company, Kangtai Biological, announced that its wholly-owned subsidiary, Beijing Minhai Biotechnology Co., Ltd., has received a drug registration certificate from the National Medical Products Administration for the Sabin strain inactivated poliovirus vaccine (Vero cells), which is intended for the prevention of acute infectious diseases caused by the poliovirus [1]. Group 1 - The drug registration certificate was issued by the National Medical Products Administration [1]. - The vaccine is specifically for the prevention of poliovirus-related acute infectious diseases [1].